Learn about respiratory viruses during viral season and how to stay safe. Dr. Matthew Muller discusses COVID-19, RSV, influenza, and more.
GlobalData on MSN12h
Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trialShionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...
Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.
The topic and treatment of contagious disease has become controversial since COVID-19 came along, but what is not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback